Natus Medical (BABY) Tops Q2 EPS by 1c

Natus Medical (NASDAQ: BABY) reported Q2 EPS of $0.34, $0.01 better than the analyst estimate of $0.33. Revenue for the quarter came in at $122.2 million versus the consensus estimate of $121.99 million.

For earnings history and earnings-related data on Natus Medical (BABY) click here.

You May Also Be Interested In

• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• Benchmark Reiterates Buy Rating on Odysight.AI Inc. (ODYS)
• Wendy's U.S. president to resign, company to create COO role